Starpharma Holdings Limited (SPHRY) Stock Competitors & Peer Comparison
See (SPHRY) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SPHRY | $5.10 | -2.63% | 214.7M | -85.00 | -$0.06 | N/A |
| NONOF | $42.11 | +2.09% | 183.6B | 9.70 | $4.26 | +4.33% |
| CSLLY | $18.15 | +6.26% | 67.3B | 11.28 | $1.54 | +4.15% |
| UCBJY | $153.07 | +1.94% | 57.8B | 32.50 | $4.67 | +0.56% |
| UCBJF | $310.09 | +6.14% | 56B | 31.56 | $9.32 | +0.58% |
| ARGNF | $885.00 | +5.99% | 54.8B | 39.26 | $22.54 | N/A |
| CMXHF | $71.00 | +0.48% | 32.4B | 10.95 | $6.17 | +4.32% |
| WXIBF | $4.40 | +0.00% | 18.2B | 25.88 | $0.17 | N/A |
| IVBXF | $9.10 | +0.00% | 15.8B | 130.00 | $0.07 | N/A |
| WXXWY | $7.59 | -2.44% | 15.7B | 22.34 | $0.34 | N/A |
Stock Comparison
SPHRY vs NONOF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, NONOF has a market cap of 183.6B. Regarding current trading prices, SPHRY is priced at $5.10, while NONOF trades at $42.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas NONOF's P/E ratio is 9.70. In terms of profitability, SPHRY's ROE is -0.05%, compared to NONOF's ROE of +0.66%. Regarding short-term risk, SPHRY is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check NONOF's competition here
SPHRY vs CSLLY Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, CSLLY has a market cap of 67.3B. Regarding current trading prices, SPHRY is priced at $5.10, while CSLLY trades at $18.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas CSLLY's P/E ratio is 11.28. In terms of profitability, SPHRY's ROE is -0.05%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, SPHRY is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check CSLLY's competition here
SPHRY vs UCBJY Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, UCBJY has a market cap of 57.8B. Regarding current trading prices, SPHRY is priced at $5.10, while UCBJY trades at $153.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas UCBJY's P/E ratio is 32.50. In terms of profitability, SPHRY's ROE is -0.05%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, SPHRY is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check UCBJY's competition here
SPHRY vs UCBJF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, UCBJF has a market cap of 56B. Regarding current trading prices, SPHRY is priced at $5.10, while UCBJF trades at $310.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas UCBJF's P/E ratio is 31.56. In terms of profitability, SPHRY's ROE is -0.05%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, SPHRY is less volatile compared to UCBJF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check UCBJF's competition here
SPHRY vs ARGNF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, ARGNF has a market cap of 54.8B. Regarding current trading prices, SPHRY is priced at $5.10, while ARGNF trades at $885.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas ARGNF's P/E ratio is 39.26. In terms of profitability, SPHRY's ROE is -0.05%, compared to ARGNF's ROE of +0.23%. Regarding short-term risk, SPHRY is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check ARGNF's competition here
SPHRY vs CMXHF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, CMXHF has a market cap of 32.4B. Regarding current trading prices, SPHRY is priced at $5.10, while CMXHF trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas CMXHF's P/E ratio is 10.95. In terms of profitability, SPHRY's ROE is -0.05%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, SPHRY is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check CMXHF's competition here
SPHRY vs WXIBF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, WXIBF has a market cap of 18.2B. Regarding current trading prices, SPHRY is priced at $5.10, while WXIBF trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas WXIBF's P/E ratio is 25.88. In terms of profitability, SPHRY's ROE is -0.05%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, SPHRY is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check WXIBF's competition here
SPHRY vs IVBXF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, IVBXF has a market cap of 15.8B. Regarding current trading prices, SPHRY is priced at $5.10, while IVBXF trades at $9.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas IVBXF's P/E ratio is 130.00. In terms of profitability, SPHRY's ROE is -0.05%, compared to IVBXF's ROE of +0.05%. Regarding short-term risk, SPHRY is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check IVBXF's competition here
SPHRY vs WXXWY Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, WXXWY has a market cap of 15.7B. Regarding current trading prices, SPHRY is priced at $5.10, while WXXWY trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas WXXWY's P/E ratio is 22.34. In terms of profitability, SPHRY's ROE is -0.05%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, SPHRY is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check WXXWY's competition here
SPHRY vs GNMSF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, GNMSF has a market cap of 15.3B. Regarding current trading prices, SPHRY is priced at $5.10, while GNMSF trades at $249.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas GNMSF's P/E ratio is 18.94. In terms of profitability, SPHRY's ROE is -0.05%, compared to GNMSF's ROE of +0.15%. Regarding short-term risk, SPHRY is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check GNMSF's competition here
SPHRY vs SBMFF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, SBMFF has a market cap of 11.3B. Regarding current trading prices, SPHRY is priced at $5.10, while SBMFF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas SBMFF's P/E ratio is 21.10. In terms of profitability, SPHRY's ROE is -0.05%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, SPHRY is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check SBMFF's competition here
SPHRY vs SBHMY Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, SBHMY has a market cap of 10.7B. Regarding current trading prices, SPHRY is priced at $5.10, while SBHMY trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas SBHMY's P/E ratio is 31.67. In terms of profitability, SPHRY's ROE is -0.05%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, SPHRY is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check SBHMY's competition here
SPHRY vs BRRGF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, SPHRY is priced at $5.10, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, SPHRY's ROE is -0.05%, compared to BRRGF's ROE of -0.97%. Regarding short-term risk, SPHRY is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check BRRGF's competition here
SPHRY vs AAVXF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, AAVXF has a market cap of 8.1B. Regarding current trading prices, SPHRY is priced at $5.10, while AAVXF trades at $101.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas AAVXF's P/E ratio is -18.89. In terms of profitability, SPHRY's ROE is -0.05%, compared to AAVXF's ROE of -1.65%. Regarding short-term risk, SPHRY is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check AAVXF's competition here
SPHRY vs ODTC Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, SPHRY is priced at $5.10, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas ODTC's P/E ratio is 1.07. In terms of profitability, SPHRY's ROE is -0.05%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, SPHRY is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check ODTC's competition here
SPHRY vs AKBLF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, AKBLF has a market cap of 6.3B. Regarding current trading prices, SPHRY is priced at $5.10, while AKBLF trades at $31.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas AKBLF's P/E ratio is 34.83. In terms of profitability, SPHRY's ROE is -0.05%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, SPHRY is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check AKBLF's competition here
SPHRY vs REGMF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, REGMF has a market cap of 5.5B. Regarding current trading prices, SPHRY is priced at $5.10, while REGMF trades at $9.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas REGMF's P/E ratio is 51.63. In terms of profitability, SPHRY's ROE is -0.05%, compared to REGMF's ROE of +0.42%. Regarding short-term risk, SPHRY is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check REGMF's competition here
SPHRY vs ABCZF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, SPHRY is priced at $5.10, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, SPHRY's ROE is -0.05%, compared to ABCZF's ROE of +0.22%. Regarding short-term risk, SPHRY is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check ABCZF's competition here
SPHRY vs TRSBF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, TRSBF has a market cap of 5B. Regarding current trading prices, SPHRY is priced at $5.10, while TRSBF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas TRSBF's P/E ratio is 3.92. In terms of profitability, SPHRY's ROE is -0.05%, compared to TRSBF's ROE of +0.38%. Regarding short-term risk, SPHRY is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check TRSBF's competition here
SPHRY vs SHJBF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, SHJBF has a market cap of 4.3B. Regarding current trading prices, SPHRY is priced at $5.10, while SHJBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas SHJBF's P/E ratio is -25.00. In terms of profitability, SPHRY's ROE is -0.05%, compared to SHJBF's ROE of -0.11%. Regarding short-term risk, SPHRY is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check SHJBF's competition here
SPHRY vs GNNSF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, GNNSF has a market cap of 3.5B. Regarding current trading prices, SPHRY is priced at $5.10, while GNNSF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas GNNSF's P/E ratio is -6.40. In terms of profitability, SPHRY's ROE is -0.05%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, SPHRY is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check GNNSF's competition here
SPHRY vs TLPPF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, TLPPF has a market cap of 3.2B. Regarding current trading prices, SPHRY is priced at $5.10, while TLPPF trades at $9.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas TLPPF's P/E ratio is -470.50. In terms of profitability, SPHRY's ROE is -0.05%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, SPHRY is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check TLPPF's competition here
SPHRY vs BRCTF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, BRCTF has a market cap of 3.1B. Regarding current trading prices, SPHRY is priced at $5.10, while BRCTF trades at $35.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas BRCTF's P/E ratio is 140.00. In terms of profitability, SPHRY's ROE is -0.05%, compared to BRCTF's ROE of +0.10%. Regarding short-term risk, SPHRY is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check BRCTF's competition here
SPHRY vs INCPF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, INCPF has a market cap of 3.1B. Regarding current trading prices, SPHRY is priced at $5.10, while INCPF trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas INCPF's P/E ratio is 34.17. In terms of profitability, SPHRY's ROE is -0.05%, compared to INCPF's ROE of +0.10%. Regarding short-term risk, SPHRY is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check INCPF's competition here
SPHRY vs ZLDPF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, ZLDPF has a market cap of 3B. Regarding current trading prices, SPHRY is priced at $5.10, while ZLDPF trades at $42.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas ZLDPF's P/E ratio is 3.03. In terms of profitability, SPHRY's ROE is -0.05%, compared to ZLDPF's ROE of +0.43%. Regarding short-term risk, SPHRY is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check ZLDPF's competition here
SPHRY vs MPSYF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, SPHRY is priced at $5.10, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, SPHRY's ROE is -0.05%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, SPHRY is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check MPSYF's competition here
SPHRY vs GENSF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, GENSF has a market cap of 2.3B. Regarding current trading prices, SPHRY is priced at $5.10, while GENSF trades at $35.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas GENSF's P/E ratio is 36.84. In terms of profitability, SPHRY's ROE is -0.05%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, SPHRY is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check GENSF's competition here
SPHRY vs BVNRY Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, BVNRY has a market cap of 2.2B. Regarding current trading prices, SPHRY is priced at $5.10, while BVNRY trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas BVNRY's P/E ratio is 11.92. In terms of profitability, SPHRY's ROE is -0.05%, compared to BVNRY's ROE of +0.09%. Regarding short-term risk, SPHRY is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check BVNRY's competition here
SPHRY vs BVNKF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, BVNKF has a market cap of 2.1B. Regarding current trading prices, SPHRY is priced at $5.10, while BVNKF trades at $27.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas BVNKF's P/E ratio is 11.84. In terms of profitability, SPHRY's ROE is -0.05%, compared to BVNKF's ROE of +0.09%. Regarding short-term risk, SPHRY is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check BVNKF's competition here
SPHRY vs MEOBF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, MEOBF has a market cap of 2B. Regarding current trading prices, SPHRY is priced at $5.10, while MEOBF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas MEOBF's P/E ratio is -22.14. In terms of profitability, SPHRY's ROE is -0.05%, compared to MEOBF's ROE of -0.14%. Regarding short-term risk, SPHRY is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check MEOBF's competition here
SPHRY vs GLPGF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, GLPGF has a market cap of 1.9B. Regarding current trading prices, SPHRY is priced at $5.10, while GLPGF trades at $28.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas GLPGF's P/E ratio is -3.50. In terms of profitability, SPHRY's ROE is -0.05%, compared to GLPGF's ROE of +0.16%. Regarding short-term risk, SPHRY is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check GLPGF's competition here
SPHRY vs PHMMF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, PHMMF has a market cap of 1.8B. Regarding current trading prices, SPHRY is priced at $5.10, while PHMMF trades at $106.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas PHMMF's P/E ratio is 46.29. In terms of profitability, SPHRY's ROE is -0.05%, compared to PHMMF's ROE of +0.36%. Regarding short-term risk, SPHRY is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check PHMMF's competition here
SPHRY vs ASPHF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, ASPHF has a market cap of 1.7B. Regarding current trading prices, SPHRY is priced at $5.10, while ASPHF trades at $4.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas ASPHF's P/E ratio is -8.71. In terms of profitability, SPHRY's ROE is -0.05%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, SPHRY is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check ASPHF's competition here
SPHRY vs ONTTF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, ONTTF has a market cap of 1.7B. Regarding current trading prices, SPHRY is priced at $5.10, while ONTTF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas ONTTF's P/E ratio is -8.60. In terms of profitability, SPHRY's ROE is -0.05%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, SPHRY is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check ONTTF's competition here
SPHRY vs BIESF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, SPHRY is priced at $5.10, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas BIESF's P/E ratio is -44.44. In terms of profitability, SPHRY's ROE is -0.05%, compared to BIESF's ROE of -0.05%. Regarding short-term risk, SPHRY is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check BIESF's competition here
SPHRY vs IDRSF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, IDRSF has a market cap of 1.5B. Regarding current trading prices, SPHRY is priced at $5.10, while IDRSF trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas IDRSF's P/E ratio is -4.42. In terms of profitability, SPHRY's ROE is -0.05%, compared to IDRSF's ROE of +0.19%. Regarding short-term risk, SPHRY is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check IDRSF's competition here
SPHRY vs ASCLF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, ASCLF has a market cap of 1.4B. Regarding current trading prices, SPHRY is priced at $5.10, while ASCLF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas ASCLF's P/E ratio is -27.00. In terms of profitability, SPHRY's ROE is -0.05%, compared to ASCLF's ROE of -0.19%. Regarding short-term risk, SPHRY is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check ASCLF's competition here
SPHRY vs HBMHF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, SPHRY is priced at $5.10, while HBMHF trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas HBMHF's P/E ratio is 13.00. In terms of profitability, SPHRY's ROE is -0.05%, compared to HBMHF's ROE of +0.28%. Regarding short-term risk, SPHRY is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check HBMHF's competition here
SPHRY vs SNBIF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, SPHRY is priced at $5.10, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, SPHRY's ROE is -0.05%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, SPHRY is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check SNBIF's competition here
SPHRY vs MDCLF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, SPHRY is priced at $5.10, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, SPHRY's ROE is -0.05%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, SPHRY is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check MDCLF's competition here
SPHRY vs NURPF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, NURPF has a market cap of 1.2B. Regarding current trading prices, SPHRY is priced at $5.10, while NURPF trades at $9.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas NURPF's P/E ratio is 57.81. In terms of profitability, SPHRY's ROE is -0.05%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, SPHRY is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check NURPF's competition here
SPHRY vs CSPHF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, CSPHF has a market cap of 1.1B. Regarding current trading prices, SPHRY is priced at $5.10, while CSPHF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas CSPHF's P/E ratio is -13.90. In terms of profitability, SPHRY's ROE is -0.05%, compared to CSPHF's ROE of -0.64%. Regarding short-term risk, SPHRY is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check CSPHF's competition here
SPHRY vs CSBTF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, CSBTF has a market cap of 1B. Regarding current trading prices, SPHRY is priced at $5.10, while CSBTF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas CSBTF's P/E ratio is 325.00. In terms of profitability, SPHRY's ROE is -0.05%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, SPHRY is less volatile compared to CSBTF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check CSBTF's competition here
SPHRY vs BTTAY Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, SPHRY is priced at $5.10, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, SPHRY's ROE is -0.05%, compared to BTTAY's ROE of -0.05%. Regarding short-term risk, SPHRY is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check BTTAY's competition here
SPHRY vs TKBIF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, SPHRY is priced at $5.10, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas TKBIF's P/E ratio is -14.60. In terms of profitability, SPHRY's ROE is -0.05%, compared to TKBIF's ROE of N/A. Regarding short-term risk, SPHRY is less volatile compared to TKBIF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check TKBIF's competition here
SPHRY vs PHGUF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, PHGUF has a market cap of 872.9M. Regarding current trading prices, SPHRY is priced at $5.10, while PHGUF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas PHGUF's P/E ratio is 61.80. In terms of profitability, SPHRY's ROE is -0.05%, compared to PHGUF's ROE of +0.05%. Regarding short-term risk, SPHRY is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check PHGUF's competition here
SPHRY vs PPTDF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, PPTDF has a market cap of 828.8M. Regarding current trading prices, SPHRY is priced at $5.10, while PPTDF trades at $5.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas PPTDF's P/E ratio is -35.83. In terms of profitability, SPHRY's ROE is -0.05%, compared to PPTDF's ROE of -0.05%. Regarding short-term risk, SPHRY is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check PPTDF's competition here
SPHRY vs BPMUF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, BPMUF has a market cap of 805.6M. Regarding current trading prices, SPHRY is priced at $5.10, while BPMUF trades at $65.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas BPMUF's P/E ratio is 9.14. In terms of profitability, SPHRY's ROE is -0.05%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, SPHRY is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check BPMUF's competition here
SPHRY vs CKDXF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, SPHRY is priced at $5.10, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, SPHRY's ROE is -0.05%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, SPHRY is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check CKDXF's competition here
SPHRY vs SOLTF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, SOLTF has a market cap of 559.6M. Regarding current trading prices, SPHRY is priced at $5.10, while SOLTF trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas SOLTF's P/E ratio is -7.01. In terms of profitability, SPHRY's ROE is -0.05%, compared to SOLTF's ROE of -0.16%. Regarding short-term risk, SPHRY is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check SOLTF's competition here
SPHRY vs IVEVF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, IVEVF has a market cap of 556.2M. Regarding current trading prices, SPHRY is priced at $5.10, while IVEVF trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas IVEVF's P/E ratio is -1.81. In terms of profitability, SPHRY's ROE is -0.05%, compared to IVEVF's ROE of +18.92%. Regarding short-term risk, SPHRY is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check IVEVF's competition here
SPHRY vs INRLF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, INRLF has a market cap of 519.6M. Regarding current trading prices, SPHRY is priced at $5.10, while INRLF trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas INRLF's P/E ratio is -2.95. In terms of profitability, SPHRY's ROE is -0.05%, compared to INRLF's ROE of -1.06%. Regarding short-term risk, SPHRY is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check INRLF's competition here
SPHRY vs GNFTF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, GNFTF has a market cap of 475.8M. Regarding current trading prices, SPHRY is priced at $5.10, while GNFTF trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas GNFTF's P/E ratio is -4.75. In terms of profitability, SPHRY's ROE is -0.05%, compared to GNFTF's ROE of -5.96%. Regarding short-term risk, SPHRY is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check GNFTF's competition here
SPHRY vs RAONF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, SPHRY is priced at $5.10, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas RAONF's P/E ratio is -43.33. In terms of profitability, SPHRY's ROE is -0.05%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, SPHRY is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check RAONF's competition here
SPHRY vs GNFTY Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, SPHRY is priced at $5.10, while GNFTY trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, SPHRY's ROE is -0.05%, compared to GNFTY's ROE of -0.65%. Regarding short-term risk, SPHRY is less volatile compared to GNFTY. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check GNFTY's competition here
SPHRY vs PTCHF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, PTCHF has a market cap of 438.2M. Regarding current trading prices, SPHRY is priced at $5.10, while PTCHF trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas PTCHF's P/E ratio is -3.91. In terms of profitability, SPHRY's ROE is -0.05%, compared to PTCHF's ROE of -0.32%. Regarding short-term risk, SPHRY is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check PTCHF's competition here
SPHRY vs AVCTF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, AVCTF has a market cap of 437.4M. Regarding current trading prices, SPHRY is priced at $5.10, while AVCTF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas AVCTF's P/E ratio is -8.33. In terms of profitability, SPHRY's ROE is -0.05%, compared to AVCTF's ROE of -29.83%. Regarding short-term risk, SPHRY is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check AVCTF's competition here
SPHRY vs BOVNF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, BOVNF has a market cap of 436.3M. Regarding current trading prices, SPHRY is priced at $5.10, while BOVNF trades at $6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas BOVNF's P/E ratio is -14.11. In terms of profitability, SPHRY's ROE is -0.05%, compared to BOVNF's ROE of -0.54%. Regarding short-term risk, SPHRY is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check BOVNF's competition here
SPHRY vs TBGNF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, SPHRY is priced at $5.10, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, SPHRY's ROE is -0.05%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, SPHRY is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check TBGNF's competition here
SPHRY vs NWPHF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, NWPHF has a market cap of 416.1M. Regarding current trading prices, SPHRY is priced at $5.10, while NWPHF trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas NWPHF's P/E ratio is -26.32. In terms of profitability, SPHRY's ROE is -0.05%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, SPHRY is less volatile compared to NWPHF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check NWPHF's competition here
SPHRY vs CYDY Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, CYDY has a market cap of 405.4M. Regarding current trading prices, SPHRY is priced at $5.10, while CYDY trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas CYDY's P/E ratio is -7.40. In terms of profitability, SPHRY's ROE is -0.05%, compared to CYDY's ROE of +0.37%. Regarding short-term risk, SPHRY is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check CYDY's competition here
SPHRY vs SPHDF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, SPHDF has a market cap of 337.7M. Regarding current trading prices, SPHRY is priced at $5.10, while SPHDF trades at $23.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas SPHDF's P/E ratio is -4.86. In terms of profitability, SPHRY's ROE is -0.05%, compared to SPHDF's ROE of +6.85%. Regarding short-term risk, SPHRY is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check SPHDF's competition here
SPHRY vs SCNLF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, SCNLF has a market cap of 325.2M. Regarding current trading prices, SPHRY is priced at $5.10, while SCNLF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas SCNLF's P/E ratio is -31.34. In terms of profitability, SPHRY's ROE is -0.05%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, SPHRY is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check SCNLF's competition here
SPHRY vs CLVLF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, CLVLF has a market cap of 322.6M. Regarding current trading prices, SPHRY is priced at $5.10, while CLVLF trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas CLVLF's P/E ratio is 14.22. In terms of profitability, SPHRY's ROE is -0.05%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, SPHRY is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check CLVLF's competition here
SPHRY vs CLVLY Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, CLVLY has a market cap of 320.6M. Regarding current trading prices, SPHRY is priced at $5.10, while CLVLY trades at $6.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas CLVLY's P/E ratio is 14.13. In terms of profitability, SPHRY's ROE is -0.05%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, SPHRY is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check CLVLY's competition here
SPHRY vs NWBO Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, NWBO has a market cap of 317.6M. Regarding current trading prices, SPHRY is priced at $5.10, while NWBO trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas NWBO's P/E ratio is -6.44. In terms of profitability, SPHRY's ROE is -0.05%, compared to NWBO's ROE of +0.62%. Regarding short-term risk, SPHRY is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check NWBO's competition here
SPHRY vs VBIZF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, VBIZF has a market cap of 316.7M. Regarding current trading prices, SPHRY is priced at $5.10, while VBIZF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas VBIZF's P/E ratio is 15.00. In terms of profitability, SPHRY's ROE is -0.05%, compared to VBIZF's ROE of +0.06%. Regarding short-term risk, SPHRY is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check VBIZF's competition here
SPHRY vs NGENF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, SPHRY is priced at $5.10, while NGENF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas NGENF's P/E ratio is -15.19. In terms of profitability, SPHRY's ROE is -0.05%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, SPHRY is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check NGENF's competition here
SPHRY vs FGHQF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, SPHRY is priced at $5.10, while FGHQF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, SPHRY's ROE is -0.05%, compared to FGHQF's ROE of +0.02%. Regarding short-term risk, SPHRY is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check FGHQF's competition here
SPHRY vs HLOSF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, HLOSF has a market cap of 290.7M. Regarding current trading prices, SPHRY is priced at $5.10, while HLOSF trades at $2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas HLOSF's P/E ratio is -15.88. In terms of profitability, SPHRY's ROE is -0.05%, compared to HLOSF's ROE of -0.75%. Regarding short-term risk, SPHRY is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check HLOSF's competition here
SPHRY vs PBBIF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, SPHRY is priced at $5.10, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, SPHRY's ROE is -0.05%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, SPHRY is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check PBBIF's competition here
SPHRY vs KNTPF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, KNTPF has a market cap of 265M. Regarding current trading prices, SPHRY is priced at $5.10, while KNTPF trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas KNTPF's P/E ratio is -8.07. In terms of profitability, SPHRY's ROE is -0.05%, compared to KNTPF's ROE of -0.63%. Regarding short-term risk, SPHRY is more volatile compared to KNTPF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check KNTPF's competition here
SPHRY vs CMVLF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, CMVLF has a market cap of 251M. Regarding current trading prices, SPHRY is priced at $5.10, while CMVLF trades at $3.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas CMVLF's P/E ratio is -10.52. In terms of profitability, SPHRY's ROE is -0.05%, compared to CMVLF's ROE of -0.81%. Regarding short-term risk, SPHRY is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check CMVLF's competition here
SPHRY vs HNSBF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, SPHRY is priced at $5.10, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas HNSBF's P/E ratio is -3.45. In terms of profitability, SPHRY's ROE is -0.05%, compared to HNSBF's ROE of +2.02%. Regarding short-term risk, SPHRY is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check HNSBF's competition here
SPHRY vs OPORF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, OPORF has a market cap of 240.9M. Regarding current trading prices, SPHRY is priced at $5.10, while OPORF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas OPORF's P/E ratio is 35.00. In terms of profitability, SPHRY's ROE is -0.05%, compared to OPORF's ROE of -0.15%. Regarding short-term risk, SPHRY is more volatile compared to OPORF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check OPORF's competition here
SPHRY vs ORYZF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, ORYZF has a market cap of 234.9M. Regarding current trading prices, SPHRY is priced at $5.10, while ORYZF trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas ORYZF's P/E ratio is -101.00. In terms of profitability, SPHRY's ROE is -0.05%, compared to ORYZF's ROE of -0.02%. Regarding short-term risk, SPHRY is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check ORYZF's competition here
SPHRY vs SPHRF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, SPHRF has a market cap of 227.3M. Regarding current trading prices, SPHRY is priced at $5.10, while SPHRF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas SPHRF's P/E ratio is -54.00. In terms of profitability, SPHRY's ROE is -0.05%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, SPHRY is more volatile compared to SPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check SPHRF's competition here
SPHRY vs IPHYF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, IPHYF has a market cap of 211.3M. Regarding current trading prices, SPHRY is priced at $5.10, while IPHYF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas IPHYF's P/E ratio is -3.52. In terms of profitability, SPHRY's ROE is -0.05%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, SPHRY is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check IPHYF's competition here
SPHRY vs FPHAF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, SPHRY is priced at $5.10, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, SPHRY's ROE is -0.05%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, SPHRY is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check FPHAF's competition here
SPHRY vs RECEF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, RECEF has a market cap of 182.6M. Regarding current trading prices, SPHRY is priced at $5.10, while RECEF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas RECEF's P/E ratio is -8.33. In terms of profitability, SPHRY's ROE is -0.05%, compared to RECEF's ROE of +2.79%. Regarding short-term risk, SPHRY is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check RECEF's competition here
SPHRY vs PHCUF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, PHCUF has a market cap of 176.4M. Regarding current trading prices, SPHRY is priced at $5.10, while PHCUF trades at $6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas PHCUF's P/E ratio is 19.50. In terms of profitability, SPHRY's ROE is -0.05%, compared to PHCUF's ROE of +0.17%. Regarding short-term risk, SPHRY is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check PHCUF's competition here
SPHRY vs ADOCY Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, SPHRY is priced at $5.10, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, SPHRY's ROE is -0.05%, compared to ADOCY's ROE of +8.60%. Regarding short-term risk, SPHRY is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check ADOCY's competition here
SPHRY vs BBIXF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, BBIXF has a market cap of 151.8M. Regarding current trading prices, SPHRY is priced at $5.10, while BBIXF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas BBIXF's P/E ratio is -13.00. In terms of profitability, SPHRY's ROE is -0.05%, compared to BBIXF's ROE of -15.41%. Regarding short-term risk, SPHRY is less volatile compared to BBIXF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check BBIXF's competition here
SPHRY vs SLNCF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, SLNCF has a market cap of 150.2M. Regarding current trading prices, SPHRY is priced at $5.10, while SLNCF trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas SLNCF's P/E ratio is -1.96. In terms of profitability, SPHRY's ROE is -0.05%, compared to SLNCF's ROE of -1.22%. Regarding short-term risk, SPHRY is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check SLNCF's competition here
SPHRY vs JWCTF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, JWCTF has a market cap of 147.9M. Regarding current trading prices, SPHRY is priced at $5.10, while JWCTF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas JWCTF's P/E ratio is -1.78. In terms of profitability, SPHRY's ROE is -0.05%, compared to JWCTF's ROE of -0.75%. Regarding short-term risk, SPHRY is less volatile compared to JWCTF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check JWCTF's competition here
SPHRY vs AMGXF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, AMGXF has a market cap of 142.5M. Regarding current trading prices, SPHRY is priced at $5.10, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, SPHRY's ROE is -0.05%, compared to AMGXF's ROE of -0.71%. Regarding short-term risk, SPHRY is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check AMGXF's competition here
SPHRY vs HBPCF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, HBPCF has a market cap of 130.6M. Regarding current trading prices, SPHRY is priced at $5.10, while HBPCF trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas HBPCF's P/E ratio is -42.75. In terms of profitability, SPHRY's ROE is -0.05%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, SPHRY is more volatile compared to HBPCF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check HBPCF's competition here
SPHRY vs AAPGV Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, SPHRY is priced at $5.10, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas AAPGV's P/E ratio is N/A. In terms of profitability, SPHRY's ROE is -0.05%, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, SPHRY is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check AAPGV's competition here
SPHRY vs TRGNF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, TRGNF has a market cap of 122.6M. Regarding current trading prices, SPHRY is priced at $5.10, while TRGNF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas TRGNF's P/E ratio is -2.83. In terms of profitability, SPHRY's ROE is -0.05%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, SPHRY is more volatile compared to TRGNF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check TRGNF's competition here
SPHRY vs PSTTF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, SPHRY is priced at $5.10, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, SPHRY's ROE is -0.05%, compared to PSTTF's ROE of N/A. Regarding short-term risk, SPHRY is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check PSTTF's competition here
SPHRY vs ATGGF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, ATGGF has a market cap of 113.4M. Regarding current trading prices, SPHRY is priced at $5.10, while ATGGF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas ATGGF's P/E ratio is N/A. In terms of profitability, SPHRY's ROE is -0.05%, compared to ATGGF's ROE of -1.34%. Regarding short-term risk, SPHRY is more volatile compared to ATGGF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check ATGGF's competition here
SPHRY vs EPRXF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, SPHRY is priced at $5.10, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, SPHRY's ROE is -0.05%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, SPHRY is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check EPRXF's competition here
SPHRY vs BRIBF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, BRIBF has a market cap of 107.8M. Regarding current trading prices, SPHRY is priced at $5.10, while BRIBF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas BRIBF's P/E ratio is -3.74. In terms of profitability, SPHRY's ROE is -0.05%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, SPHRY is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check BRIBF's competition here
SPHRY vs ADOIF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, SPHRY is priced at $5.10, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, SPHRY's ROE is -0.05%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, SPHRY is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check ADOIF's competition here
SPHRY vs ORPOF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, ORPOF has a market cap of 99.4M. Regarding current trading prices, SPHRY is priced at $5.10, while ORPOF trades at $4.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas ORPOF's P/E ratio is -4.53. In terms of profitability, SPHRY's ROE is -0.05%, compared to ORPOF's ROE of N/A. Regarding short-term risk, SPHRY is more volatile compared to ORPOF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check ORPOF's competition here
SPHRY vs MSCLF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, MSCLF has a market cap of 96.6M. Regarding current trading prices, SPHRY is priced at $5.10, while MSCLF trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas MSCLF's P/E ratio is 2.43. In terms of profitability, SPHRY's ROE is -0.05%, compared to MSCLF's ROE of -0.61%. Regarding short-term risk, SPHRY is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check MSCLF's competition here
SPHRY vs MLLCF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, MLLCF has a market cap of 95.7M. Regarding current trading prices, SPHRY is priced at $5.10, while MLLCF trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas MLLCF's P/E ratio is -1.30. In terms of profitability, SPHRY's ROE is -0.05%, compared to MLLCF's ROE of -0.66%. Regarding short-term risk, SPHRY is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check MLLCF's competition here
SPHRY vs MCURF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, SPHRY is priced at $5.10, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas MCURF's P/E ratio is -16.90. In terms of profitability, SPHRY's ROE is -0.05%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, SPHRY is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for SPHRY.Check MCURF's competition here
SPHRY vs POLBF Comparison June 2026
SPHRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SPHRY stands at 214.7M. In comparison, POLBF has a market cap of 81.4M. Regarding current trading prices, SPHRY is priced at $5.10, while POLBF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SPHRY currently has a P/E ratio of -85.00, whereas POLBF's P/E ratio is -11.54. In terms of profitability, SPHRY's ROE is -0.05%, compared to POLBF's ROE of -0.55%. Regarding short-term risk, SPHRY is more volatile compared to POLBF. This indicates potentially higher risk in terms of short-term price fluctuations for SPHRY.Check POLBF's competition here